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Objective: Mature lobar transplantation will increase the pediatric donor 
organ pool, but it remains unknown whether such grafts will grow in a 
developing recipient and provide adequate long-term support. We hypothe- 
sized that a mature pulmonary lobar allograft implanted in an immature 
recipient would grow. Methods: We investigated our hypothesis in a porcine 
orthotopic left lung transplant model using animals matched by the major 
histocompatibility complex to minimize the effects of chronic rejection. Twenty- 
three immature animals (< 12 weeks of age and < 10 kg total body weight) 
received either sham left thoracotomy (SH control, n = 4), left upper lobectomy 
to study compensatory growth (UL control, n = 4), age-matched immature 
whole left lung transplants (IWL TXP, n = 6), mature (donor > 1 yr in age 
and > 40 kg in total body weight) left lower lobe transplants (MLL TXP, n = 
5), or mature left upper lobe transplants (MUL TXP, n = 4). Twelve weeks 
after implantation, functional residual capacity of the left lung was measured 
and arterial blood gas samples were obtained after the native right lung had 
been excluded. The graft was excised and weighed, and samples for microscopy 
and wet/dry ratios were collected. Results: Initial and final graft weights were as 
follows: IWL TXP group (34.6 _ 1.5 and 107.8 - 5.9 gm, p < 0.0001), MLL 
TXP group (72.4 -+ 6.8 and 111.4 + 8.7, p < 0.001), and MUL TXP group 
(32.8 - 1.3 and 92.8 - 7.1 gm, respectively, p < 0.004). No significant 
differences between groups were demonstrated when functional residual ca- 
pacity, wet/dry ratios, or oxygenation were compared. Immunohistochemical 
staining for the nuclear antigen Ki-67 demonstrated dividing pneumocytes. 
Conclusions: We conclude that a mature lobar graft implanted into an 
immature recipient grows by pneumocyte division in this model. Mature lobar 
transplants can be expected to grow and provide adequate long-term function 
in developing recipients. (J Thorac Cardiovasc Surg 1997;114:186-94) 
D espite advances in all aspects of pulmonary transplantation, this successful therapeutic op- 
tion remains limited by a critical shortage of suitable 
donors. Approximately 25 % of patients on recipient 
lists will die of their underlying pulmonary disease 
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while awaiting identification of a suitable donor. 1 
The pediatric population awaiting lung transplanta- 
tion is further restricted as organ availability is 
limited by size discrepancies between the potential 
recipient and donor. 2 Reduced-size lung transplan- 
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tation has been studied in experimental models and 
applied clinically. 3' 4 Such a strategy could provide a 
partial solution to the critical donor shortage and 
the difficulties related to size disparity in pediatric 
lung transplantation. 
In addition to a paucity of lung donors, the other 
critical issue in pediatric lung transplantation per- 
tains to lung growth. It remains unknown whether a 
transplanted graft will continue to develop in a 
growing individual, thus supporting the long-term 
respiratory requirements of the recipient/ Growth 
potential is especially in question when pertaining to 
mature reduced-size grafts, and the long-term effi- 
cacy of these grafts has been questioned. 6 It is 
possible that such grafts may serve only as a tempo- 
rary bridge to retransplantation, at which time the 
recipient's thorax could accommodate an anatomi- 
cally mature lung. Our laboratory has previously 
reported growth of a mature lobar transplant in a 
domestic swine model as noted by gross weights and 
fixed lung volumes. 7 However, a possible limitation 
of this study may have been the effects of chronic 
rejection. In addition, the cell type responsible for 
this growth was not identified, nor was the growth 
potential of transplanted immature lung tissue in- 
vestigated. In an effort to minimize the confounding 
effects of chronic rejection in these long-term stud- 
ies and ensure transplantation f fully mature donor 
lung tissue, we developed a similar model in a strain 
of miniature swine matched according to major 
histocompatibility complex (MHC). 8 In the present 
study we investigated the growth and function of 
immature whole lungs, mature lower lobes, and 
mature upper lobes transplanted into immature 
recipients using an orthotopic left lung transplant 
model. To identify the cell type responsible for lung 
growth, we used an immunohistochemical staining 
method that uses an antibody to the nuclear antigen 
Ki-67. 
Materials and methods 
Experimental protocol. Twenty-three immature swine 
comprised five study groups: two control groups and three 
transplant recipient groups. Nine mature and six imma- 
ture swine (MHC-matched with recipients) served as lung 
donors. Immature recipients were less than 12 weeks of 
age and averaged 9.7 kg in total body weight. Mature 
donors were at least 1 year of age and averaged 42.2 _+ 6.4 
kg in total body weight. Immature donors were age- and 
size-matched with the recipients, averaging 7.9 _+ 0.5 kg in 
total body weight. Group I (SH control) underwent sham 
left thoracotomy (n = 4). Group II (UL control) under- 
went left upper lobectomy (n = 4). Group III (IWL TXP) 
received age- and size-matched immature whole left lung 
transplants (n = 6). Group IV (MLL TXP) received 
mature left lower lobe transplants (n = 5). Group V 
(MUL TXP) received mature left upper lobe transplants 
(n = 4). All lungs were flushed with cold Euro-Collins 
solution before preparation of the graft for implantation. 
After transplantation the animals were allowed to develop 
for 12 weeks before final study. 
Harvest procedure. In accordance with the following 
experimental model, previously described by our labora- 
tory,9, lO nine adult Hanford miniature swine served as 
mature lobar donors. Six immature age-, size-, and MHC- 
matched swine served as immature whole lung donors. 
Anesthesia was maintained with 2.0% inhalational halo- 
thane. A left posterolateral thoracotomy was performed. 
The hemiazygos vein was ligated and divided, facilitating 
exposure to the left hilum. The incomplete fissure be- 
tween the left upper lobe and lower lobe was sharply 
divided in the mature lobar donors. Care was taken to 
carry out the dissection on the side of the unused lobe so 
as to avoid air leaks in the recipient. Each animal was then 
given intravenous heparin sodium (200 U/kg). The main 
pulmonary artery was clamped and a 16-gauge catheter 
was inserted into the distal vessel. A left atriotomy was 
then performed to vent the heart. One liter of Euro- 
Collins solution at 4 ° C was infused into the pulmonary 
artery from a height of 30 cm. Topical cooling was 
achieved with cold saline slush. Room air ventilation 
was continued uring the Euro-Collins flush. The lung was 
then excised and prepared for implantation. 
Mature lobar grafts were prepared for implantation ex 
vivo. Lower lobe grafts were prepared by performing an 
upper lobectomy. The donor lower lobe pulmonary artery 
and bronchus were then transected. The pulmonary artery 
was transected just distal to the lingular artery while still 
allowing enough length to perform the anastomosis with- 
out obstructing the artery to the superior segment. In 
animals in which the lingular artery branched off distally, 
it was ligated and the anastomosis was performed proxi- 
mal to the takeoff. The bronchus was divided as close to 
the takeoff of the sixth segmental bronchus as possible. 
Upper lobe grafts were prepared by performing a left 
lower lobectomy. The upper lobe bronchus was prepared 
with a cuff of main-stem bronchus to allow for size 
mismatching. The venous anastomoses were accom- 
plished with a left atrial cuff. The upper and lower lobe 
veins were identified as they entered the atrium and they 
were appropriately ligated. Before implantation all grafts 
were weighed. 
Recipient pneumonectomy and implantation. Fifteen 
immature MHC-matched swine underwent a left pneumo- 
nectomy and served as left lung recipients. In addition, 
four immature animals underwent a sham left thoracot- 
omy and four animals underwent a standard left upper 
lobectomy. All animals received cyclosporine (18 mg/kg) 
(Sandimmune, Sandoz Pharmaceuticals Corp., East 
Hanover, N.J.; INN: ciclosporin) and aspirin (325 mg) 1 
day before transplantation. Azathioprine (1 mg/kg) and 
methylprednisolone (500 rag) were administered intrave- 
nously along with cefazolin (250 rag) before making the 
skin incision. Anesthesia was maintained with 1.5% inha- 
lational isofturane. Through a left posterolateral thoracot- 
omy, the left lung was mobilized and the hilum dissected 
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Fig. 1. Chest roentgenogram demonstrating ormal aer- 
ation of a mature lower lobe transplant after 12 weeks of 
development. 
as in the donor pigs. Dissection around the recipient 
bronchus was minimized. The recipient was then given 
with intravenous heparin sodium (200 U/kg), the pulmo- 
nary artery was clamped, and the pulmonary veins and 
pulmonary artery were ligated and divided. The left 
main-stem bronchus was then lightly clamped, and the left 
lung was excised. 
Implantation commenced with the bronchial anastomo- 
sis, followed by the pulmonary arterial and left atrial 
anastomoses. All anastomoses were performed with ab- 
sorbable suture to allow for growth. The bronchial anas- 
tomosis was done with a continuous 5-0 monofilament 
polydioxanone suture (PDS II, Ethicon, Inc., Somerville, 
N.J.). The donor bronchus was intussuscepted into the 
recipient bronchus approximately 4 to 6 mm to achieve a 
telescoping anastomosis. In animals receiving mature 
lower lobe grafts, the recipient bronchus was telescoped 
into the donor bronchus. The large diameter of the 
mature lower lobe donor bronchus as compared with the 
immature recipient's main-stem bronchus necessitated 
this difference in technique. The graft was ventilated with 
100% oxygen until completion of the remaining anasto- 
moses. The pulmonary arterial anastomosis was then 
completed with a continuous 6-0 polydioxanone suture 
and the left atrial cuff anastomosis was carried out with a 
continuous 5-0 polydioxanone suture. Intercostal nerve 
blocks were performed with 0.25% bupivacaine HC1 (Sen- 
sorcaine, Astra Pharmaceutical Products, Westborough, 
Mass.). The chest wall was closed in layers, with a chest 
tube connected to a waterseal chest drainage system 
(Atrium Medical Corp., Hudson, N.H.) being left in place. 
All animals were extubated within 1 hour after the 
operation. 
Immunosuppression consisted of cyclosporine (18 
mg/kg per day), azathioprine (1 mg/kg per day), and 
corticosteroids. Cyclosporine was continued for 7 days. 
Azathioprine was continued for the full 3-month growth 
period. Methylprednisolone (500 mg/day) was adminis- 
tered daily for 7 days and then switched to maintenance 
prednisone (2 mg/kg by mouth four times daily), which 
was continued for 3 months. Additionally, each animal 
received a daily 325 mg aspirin tablet and sulfamethox- 
azole-trimethoprim (Bactrim DS, Hoffmann-LaRoche) 
one tablet by mouth twice a day. Cefazolin (250 mg four 
times a day) was continued for 7 days after the operation. 
Chest roentgenograms were obtained 6weeks after trans- 
plantation and at the time of the final study. 
All animals received humane care in accordance with 
the "Guide for the Care and Use of Laboratory Animals" 
(National Institutes of Health Publication No. 85-23, 
revised 1985.) The protocol was reviewed and approved by 
the Animal Review Committee of the University of Vir- 
ginia. 
Data eolleetion. After 3 months of development, a 
second chest roentgenogram was obtained to document 
aeration of the transplanted lung. A tracheostomy was 
then performed, through which a 9F cuffed endotracheal 
tube was inserted. The right carotid artery and i ternal 
jugular vein were dissected, and a 16-gauge catheter was 
placed in the carotid artery for pressure measurements 
and blood gas analysis. A large-bore introducer was 
placed in the right internal jugular vein for intravenous 
access. Bronchoscopic examination was performed with a 
flexible pediatric bronchoscope (3.5 mm outer diameter). 
The bronchial anastomosis was examined for evidence of 
narrowing or technical complications. 
Lung volumes. Functional residual capacity (FRC) data 
were recorded uring double lung ventilation and again 
after exclusion of the native right lung. FRC was calcu- 
lated by means of the helium dilution technique, is FRC of 
the transplanted lung was obtained by occluding the 
native right lung airways with a 6F Fogarty balloon 
catheter (model CV1048, Baxter Healthcare Corp., Santa 
Ana, Calif.). The catheter was positioned and inflated in 
the right main-stem bronchus under direct vision with the 
aid of a bronchoscope. The right eparterial bronchus, 
present in swine, was occluded by intubation of the 
proximal left main-stem bronchus. The endotracheal tube 
cuff was then inflated to occlude the airway to the right 
upper lobe. 
Studies of gas exchange. Blood gas measurements were 
obtained under conditions of double lung ventilation 
and again during single lung ventilation 15 minutes 
after clamping of the right hilum. Arterial blood spec- 
imens were collected during room air ventilation and 
with an inspired oxygen fraction of 70%. Blood gas 
samples were run on a Corning blood gas analyzer 
(Coming 178 pH/Blood Gas Monitor; CIBA-Corning 
Diagnostics Corporation, Medfield, Mass.). 
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Fig. 2. Comparison between explanted lung weight (Explant Wt) and graft weight (Graft Wt) at the time 
of implantation. Mature lower lobe grafts (MLL TXP) were significantly larger than the recipient's 
explanted lung. 
Graft weight measurements. At the completion of the 
study, the animal was killed with a lethal dose of sodium 
pentobarbital, nd the transplanted lung was excised. The 
transplanted graft was then weighed and samples for 
wet/dry analysis, microscopy, and immunohistochemical 
staining were obtained. Control lungs and lower lobes 
from the upper lobectomy control group were treated 
similarly. 
Immunohistochemical staining. Ki-67 is a nuclear non- 
histone that begins to be expressed in the late G1 phase, 
accumulates inthe S phase, and reaches maximal levels in 
the M phase of the cell cycle. This nuclear protein is then 
rapidly lost from postmitotic cells. 12' 13 For detection of 
Ki-67 antigen, the monoclonal ntibody MIB-1 (AMAC, 
Westbrook, Mass.) was applied to paraffin-embedded 
tissue sections. Immunohistochemistry udies were per- 
formed by means of the avidin-biotin complex method 
modified by a microwave pretreatment of the paraffin 
sections for antigen retrieval. 14 An automated immuno- 
stainer (Ventana ES Automated Slide Stainer, Ventana 
Medical Systems, Tucson Ariz.) was used to ensure uni- 
form staining. 
Statistical analysis. Measurements are reported as the 
mean -+ the standard error of the mean. Analysis of 
variance was used to determine whether significant differ- 
ences existed between groups. Ap value of 0.05 or less was 
used to indicate asignificant difference between measure- 
ments. 
Resu l ts  
Technical results. The mean ischemic times were 
as follows and demonstrate a trend toward increased 
ischemia for the mature lower lobe transplants: IWL 
TXP group (90.3 + 3.9 minutes) and MUL TXP 
group (101.0 _+ 6.1 minutes) versus MLL TXP group 
(110.2 + 7.4 minutes),p = 0.074. No prolonged air 
leaks developed, and all chest tubes were removed 
by postoperative day 2. All animals demonstrated 
normal aeration of the transplanted lung (Fig. 1). 
No airway complications of functional significance 
were identified. A granuloma developed at the 
anastomotic site in an immature whole lung recipi- 
ent OWL TXP group), and this granuloma resulted 
in a 20% narrowing of the airway. One mature lower 
lobe recipient (MLL TXP group) had an insignifi- 
cant narrowing caused by a small cartilaginous shelf 
at the anastomosis. 
Measurements  of mass. Total body weight in- 
creased significantly in all animals. The mean recip- 
ient body weights at the time of transplantation were 
as follows: 9.1 __ 1.4 kg (SH control), 10.8 -+ 1.4 kg 
(UL control), 9.1 _+ 0.7 kg (IWL TXP), 9.8 _+ 1.3 kg 
(MLL TXP), and 10.1 _+ 1,4 kg (MUL TXP). After 
12 weeks of development the total body weights 
were as follows: 26.0 + 2.0 kg (SH control), 26.8 -+ 
1.6 kg (UL control), 26.0 +_ 1.1 kg (IWL TXP), 
28.3 _+ 2.3 kg (MLL TXP), and 26.0 _+ 1.5 kg (MUL 
TXP), demonstrating no differences in final body 
weights among the groups (p = 0.81). The mean 
graft weights at the time of implantation were 
34.6 _+ 1.5 gm (IWL TXP), 72.4 _+ 6.8 gm (MLL 
TXP), and 32.8 _+ 1.3 gm (MUL TXP), demonstrat- 
ing significantly arger lower lobe grafts (p < 0.001) 
(Fig. 2). The recipients' mean explanted lung 
weights at the time of implantation were 41.5 _+ 2.0 
gm (IWL TXP), 42.2 +_ 5.6 gm (MUL TXP), and 
38.3 _+ 4.5 gm (MLL TXP). The mean lung weights 
after 12 weeks of development were as follows: 
75.5 +_ 5.8 gm (SH control), 80.1 _+ 7.3 gm (UL 
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Fig. 3. Initial graft weights at the time of implantation versus the final graft weights after 12 weeks of 
development. All groups demonstrated significant increases in lung mass, and no differences in final lung 
weight were demonstrated between groups. 
control), 107.9 + 5.9 gm (IWL TXP), 111.4 _+ 8.7 
gm (MLL TXP), and 92.8 + 7.1 gm (MUL TXP), 
revealing significant increases in initial versus final 
graft weights (Fig. 3). Final/initial graft weight 
ratios for the transplant groups are as follows: 3.1 
(IWL TXP), 1.5 (MLL TXP), and 2.8 (MUL 
TXP). The graft/body weight ratios after 12 weeks 
of development are as follows: 0.0029 + 0.0001 
(SH control), 0.0030 _+ 0.0003 (UL control), 
0.0041 _+ 0.0001 (IWL TXP), 0.0040 _+ 0.0003 
(MLL TXP), and 0.0036 + 0.0005 (MUL TXP), 
p = 0.001 (Fig. 4). 
Functional results. The FRC was determined 
with double lung ventilation and again after exclud- 
ing the native right lung, thereby reflecting the 
volume of only the transplanted graft. The double 
lung FRC and single lung FRC are depicted in 
Table I. Oxygenation was equivalent between 
groups with an inspired oxygen fraction of 70%; 
however, worsening oxygenation i  the IWL TXP 
group was demonstrated with the animals breathing 
room air (Table I). Wet/dry ratios were as follows 
and revealed no significant differences between 
groups: 4.88 _+ 0.14 (SH control), 4.70 _+ 0.10 (UL 
control), 4.84 + 0.13 (IWL TXP), 4.72 + 0.17 (MLL 
TXP), and 4.37 _+ 0.33 (MUL TXP) (Table I). 
Immunohistoehemieal staining. Immunohisto- 
chemical staining for Ki-67 demonstrated dividing 
pneumocytes in all transplant groups and control 
groups (Fig. 5). Dividing inflammatory cells, includ- 
ing lymphocytes and polymorphonuclear leukocytes, 
were also stained. These cells were distinguished 
from pneumocytes by their morphologic haracter- 
istics. 
Diseussion 
Lung transplantation has been increasing applied 
in the pediatric population to treat a diverse group 
of primary pulmonary diseases, as well as secondary 
pulmonary hypertension as a result of congenital 
heart disease. 15 Two critical issues are especially 
pertinent o pediatric lung transplantation. Most 
important, donor lung availability has limited the 
number of transplant procedures being performed. 
Second, it remains unknown whether transplanted 
lung tissue will continue to grow in a developing 
recipient to the extent hat functional demands as an 
adult can be supported. 
Mortality rates remain high on waiting lists for 
pediatric lung transplantation. A 32% mortality rate 
has been reported for pediatric patients awaiting 
identification of a suitable donor. 2 Appropriate size 
matching for small recipients places further restric- 
tions on the number of available organs for pediatric 
transplantation, and only 44 pediatric lung or heart- 
lung transplantations were undertaken in 1995.16 
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Fig. 4. Graft/body weight ratios at the time of f nalstudy demonstrate significantly higher ratios when 
comparing the immature whole lung and mature lower lobe transplant groups with the control lobectomy 
and sham thoracotomy groups. 
Table I. FRCs and wet~dry ratios demonstrate no significant differences between groups 
Pao 2 Pao 2 
FRC FRC transplant lung transplant lung 
double lung transplant lung Wet~dry room air Fio 2 70% 
Groups (mI) (ml) ratio (ram Hg) (ram Hg) 
SH control  504.5 _+ 51.6 258.5 _+ 24.2 4.9 2 0.1" 85.2 ± 9.8 435.5 ± 68.9 
UL  control 527.5 ± 47.0 270.5 ± 32.8 4.7 ± 0.1 104.4 ± 11.6 382.2 _+ 40.6 
IWL  TXP 457.2 ± 16.6" 200.5 ± 23.7t 4.8 ± 0.1 63.8 -+ 4.25 318.2 -+ 48.9§ 
MUL TXP 544.2 _+ 21.6 292.1 _+ 24.5 4.4 -_~ 0.5 74.0 ± 12.8 482.3 ± 19.2 
MLL  TXP 466.4 + 37.2 244.0 + 11.3 4.7 ± 0.2 77.3 +_ 8.8 327.5 _+ 37.4 
A trend toward decreased FRC with the use of immature whole lungs is revealed. Immature whole lung transplants (ILW TXP) also demonstrated a 
significantly ower oxygenation on r om air when compared with the upper lobectomy control group. (UL control). For description of groups, see text. Pao> 
Arterial oxygen tension; Fio2, inspired oxygen fraction. 
*p = Not significant. 
tp = 0.12 versus MUL TXP. 
~p 0.04 versus UL. 
§p = 0.21 versus MUL TXP. 
Given this critical shortage of available organs, 
alternative r duced-size lung transplants have been 
proposed and used clinically. < 17, 18 Although the 
intermediate r sults with reduced-size lobar trans- 
plants are encouraging, no long-term human data 
documenting continued growth of these grafts exists, 
nor is it known whether the functional capacity of 
these grafts can continue to support an immature 
recipient into adulthood. The growth potential of 
mature pulmonary tissue transplanted into an im- 
mature environment remains unknown. Dunnil119 
reported that development of new alveolar units is 
virtually completed by 8 years of life and that 
subsequent growth in lung volume occurs by an 
increase in linear dimensions. He further speculated 
that regeneration of the lung was unlikely after that 
age. Thurlbeck 2° later reported data supporting 
Dunnill's conclusion that the majority of alveoli are 
present by 2 years of life and that alveolar multipli- 
cation after that time is limited or does not occur at 
all. Can mature lung tissue regain its potential for 
further development? What effects does transplan- 
tation have on lung development? Transplantation 
departs from the normal developmental scenario as 
the graft is influenced by a new recipient environ- 
ment, altered functional demands, host immuno- 
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Fig. 5. Immunohistochemical staining for Ki-67 demonstrating dividing pneumocytes. 
logic responses, and immunosuppressive drugs. The 
long-term success of pediatric lung transplantation 
will require a transplanted graft, immature or ma- 
ture, to continue to develop, both functionally and 
anatomically. 
Several studies have demonstrated that immature 
lung tissue can continue to develop after transplan- 
tation. Haverich and coworkers 5 reported that lung 
transplantation i growing piglets resulted in an 
increase in graft size in proportion to the somatic 
growth of the recipient organism; however, they also 
noted that somatic growth in transplant recipients 
was retarded as compared with growth in animals 
not receiving transplants. In a Lewis rat model, 
Hislop and coworkers 21 concluded that the imma- 
ture!lung will continue to grow by formation of new 
alveolar units and hypertrophy ofexisting units after 
left lung transplantation. Our results corroborate 
these findings, as the immature whole lung trans- 
plants demonstrated a 212% increase in overall 
mass during the 12-week posttransplantation devel- 
opmental period. These lungs also demonstrated a 
final FRC comparable with that of the mature lobar 
transplant recipients and control groups. We did not 
witness any aberrations in somatic growth asa result 
of the transplantation process or immunosuppres- 
sive therapy, although in this MHC-matched model 
cyclosporine was continued for only 7 days after the 
operation. Therefore immature lungs can continue 
to develop after t ansplantation, but can mature 
lung tissue? 
To date, no clinical data and minimal experimen- 
tal data exist to demonstrate hat transplanted ma- 
ture lung tissue can regain its previous develop- 
mental potential. Crombleholme and colleagues 3 
demonstrated the feasibility of lobar transplantation 
as they investigated the hemodynamic responses in 
an immature swine model, identifying the growth 
potential of a denervated mature lobar graft in a 
neonate as "another uncharted area." Although 
Backer and associates 2z again succeeded with lobar 
transplantation i  a survival model, their study was 
limited; because only two animals survived for an 
extended period, they were unable to demonstrate 
growth. Lillehei, Everts, and Shamberger 23 were 
able to transplant oversized mature grafts using 
staple pneumoreduction; however they too recog- 
nized that "the crucial unanswered issue is the 
long-term function and growth of these reduced-size 
allografts." Our group was the first to demonstrate 
the growth of mature lobar transplants in a porcine 
model] This growth was determined by gross weight 
and fixed lung volumes, but no increase in FRC was 
observed and the tissue component responsible for 
this increase in mass was not identified. 
Our data support the finding of lung growth after 
mature lobar transplantation. All animals demon- 
strated normal somatic growth when compared with 
the sham thoracotomy control group (SH control), 
averaging an increase in body weight of 172% 
during the 12-week posttransplantation develop- 
mental period. During this time the transplanted 
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grafts increased 212% (IWL TXP group), 183% 
(MUL TXP group), and 54% (MLL TXP group) in 
mass. The diminished increase seen with the mature 
lower lobes is due to their greater initial weight at 
the time of implantation. When the graft/body 
weight ratios are compared, the transplant groups 
had higher ratios than both the sham thoracotomy 
(SH control) and upper lobectomy (UL control) 
control groups. The difference reached significance 
when control groups were compared with the imma- 
ture (IWL TXP) and mature (MLL TXP) transplant 
groups. Extravascular water content could easily 
explain an apparent increase in mass. However the 
wet/dry ratios were similar among all groups, 
thereby confirming an increase in parenchymal e e- 
ments. An appropriate increase in air space of the 
transplanted lung tissue was also seen, for the 
groups were equivalent when their FRCs were com- 
pared at the end of the developmental period. 
The mechanism by which this apparent lung 
growth proceeds continues to be speculative. 
Whether the increase in weight and air-space vol- 
ume represents the formation of new alveoli or 
simply an increase in size of those alveoli present 
has been debated. From our results we cannot 
comment on alveolar size or numbers of functional 
units because morphometric techniques were not 
used. Many authors believe the theory and practice 
of counting alveoli are inaccurate and that morpho- 
metric evaluation of the lung is technically diffi- 
cult. 24 We have, however, demonstrated definitively 
that dividing pneumocytes are present in trans- 
planted mature lung tissue that has undergone an 
increase in mass and air-space volume. Using an 
immunohistochemical stain for the proliferating cell 
marker Ki-67, we have identified the presence of 
dividing pneumocytes in both immature and mature 
transplanted lung tissue. Such a finding in this 
MHC-matched model with minimal rejection leads 
us to conclude that the observed increase in mass is 
due to an increased number of pneumocytes. Thus 
lung growth occurs by hyperplasia s the trans- 
planted lung tissue attempts to maintain an ade- 
quate gas exchange surface area. The role of these 
dividing pneumocytes, whether it be the formation 
of additional gas exchange units or the enlargement 
of existing units, will require further studies. 
Similarly, the origin of these dividing pneumo- 
cytes remains unknown and is currently under inves- 
tigation in our laboratory. Even during normal 
growth and development, the exact precursor cell of 
type 1 and type 2 pneumocytes is debated. Type 1 
cells may be derived from undifferentiated pithelial 
cells or from differentiated type 2 pneumocytes. 
Terminal differentiation i volves the loss of prolif- 
erative potential, and it is thought hat type 1 cells 
cannot be induced to proliferate in mature lung, 
whereas type 2 pnuemocytes may act as stem cells, 
providing new type 1 cells to line the gas exchange 
surfaces.25, 26The effects of transplantation a d the 
new host environment on mature lung tissue remain 
unknown. We have identified ividing pneumocytes 
in transplanted mature lung tissue. However, we 
have not determined at this time whether they 
represent (1) type 1 pneumocytes that have regained 
the potential for division or (2) cells derived from 
type 2 pneumocytes acting as a type of pleuripotent 
stem cell. The mechanisms responsible for pneumo- 
cyte differentiation and proliferation need to be 
determined, and transplantation models may pro- 
vide unique insight into these issues. 
Previous studies have implicated the volume of 
the thoracic cavity in the regulation of lung growth 
and regeneration. Early work by Cohn 27 in a rat 
model attempted to demonstrate that the increase 
in lung size is due "solely to the mechanical stimulus 
of the change in pull exerted by the alteration in size 
of the thoracic cage which the lung must fill." He 
concluded that removal of lung tissue is followed by 
restitution of lung weight in proportion to the body 
weight of the animal. Similarly, our data suggest that 
the host environment has an effect on final lung 
mass and volume after transplantation and after 
lobectomy. Although there was a trend toward 
larger final graft weights with MLL transplants 
(MLL TXP group), differences between groups 
were not significant. Regardless of initial graft 
weight, which ranged from 32.8 gm in the mature 
upper lobe transplant group (MUL TXP) to 72.4 gm 
in the mature lower lobe group (MLL TXP), the 
smaller mature upper lobe grafts reached a final 
weight and FRC that did not differ significantly from 
those of the controls or the initially larger mature 
lower lobe grafts. The upper lobectomy control 
group (UL control) had a final lower lobe weight 
comparable with that of the sham control eft lungs, 
suggesting that regeneration occurred until the ex- 
pected final lung weight was achieved. This similar- 
ity in final organ size, regardless of initial size, 
suggests that the recipient environment plays a 
regulatory role in lung growth and determination of
final lung size. The mechanism for this regulation 
likely pertains to functional demands, but that re- 
mains to be elucidated. 
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In conclusion, we have demonstrated growth of 
mature pulmonary lobar allografts after implanta- 
tion into an immature recipient using an MHC- 
matched porcine model. Extravascular water con- 
tent is not responsible for the observed increase in 
allograft mass. This growth occurs by hyperplasia, 
inasmuch as dividing pneumocytes were identified 
with the use of an immunohistochemical stain for 
the nuclear antigen Ki-67. Similarly, compensatory 
lung growth after lobectomy occurs by hyperplasia. 
When comparing lung function between mature 
lobar transplants, immature whole lung transplants, 
and control thoracotomies, we identified no signifi- 
cant differences. Either mature lobar grafts or im- 
mature whole lung grafts can be expected to grow 
and provide excellent long-term function in devel- 
oping recipients, provided rejection is adequately 
controlled. 
Technical advice of Anthony J. Herring is acknowl- 
edged. 
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